scholarly article | Q13442814 |
P50 | author | Lori C Sakoda | Q89685276 |
P2093 | author name string | Louise M Henderson | |
Hormuzd A Katki | |||
Karen J Wernli | |||
Tanner J Caverly | |||
P2860 | cites work | Lung cancer screening | Q83394751 |
Prognosis and prognostic research: validating a prognostic model | Q83939735 | ||
A nomogram for predicting the risk of invasive pulmonary adenocarcinoma for patients with solitary peripheral subsolid nodules | Q88746735 | ||
Predicting Malignant Nodules from Screening CTs | Q88804005 | ||
Lung cancer susceptibility model based on age, family history and genetic variants | Q21091204 | ||
Benefits and harms of CT screening for lung cancer: a systematic review | Q24600624 | ||
Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines | Q27025828 | ||
Reduced lung-cancer mortality with low-dose computed tomographic screening | Q28241954 | ||
A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers | Q28259916 | ||
The meaning and use of the area under a receiver operating characteristic (ROC) curve | Q29547182 | ||
American Cancer Society lung cancer screening guidelines | Q30414481 | ||
Existing general population models inaccurately predict lung cancer risk in patients referred for surgical evaluation | Q30417598 | ||
Pro-surfactant protein B as a biomarker for lung cancer prediction. | Q30560535 | ||
Probability of cancer in pulmonary nodules detected on first screening CT. | Q30573941 | ||
Predicting lung cancer prior to surgical resection in patients with lung nodules | Q30610197 | ||
Assessing the generalizability of prognostic information | Q33540894 | ||
Assessment of the cancer risk factors of solitary pulmonary nodules | Q33710108 | ||
Development and validation of a lung cancer risk prediction model for African-Americans | Q33788556 | ||
An expanded risk prediction model for lung cancer | Q33788568 | ||
Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules | Q33900761 | ||
Recent methods for polygenic analysis of genome-wide data implicate an important effect of common variants on cardiovascular disease risk | Q34059030 | ||
Comparison of discriminatory power and accuracy of three lung cancer risk models | Q34059668 | ||
Variations in lung cancer risk among smokers. | Q34184504 | ||
Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Sc | Q34308138 | ||
Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement | Q34394907 | ||
A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules | Q34433475 | ||
Prediction of lung cancer risk in a Chinese population using a multifactorial genetic model | Q34507724 | ||
Decision curve analysis: a novel method for evaluating prediction models | Q34581068 | ||
Individualized risk prediction model for lung cancer in Korean men | Q34585888 | ||
Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts | Q34611247 | ||
A risk model for lung cancer incidence | Q34966064 | ||
Novel and convenient method to evaluate the character of solitary pulmonary nodule-comparison of three mathematical prediction models and further stratification of risk factors | Q35036257 | ||
Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation. | Q35090585 | ||
Development and validation of risk prediction algorithms to estimate future risk of common cancers in men and women: prospective cohort study | Q35204017 | ||
A simple model for predicting lung cancer occurrence in a lung cancer screening program: The Pittsburgh Predictor | Q35688591 | ||
The cytokinesis-blocked micronucleus assay as a strong predictor of lung cancer: extension of a lung cancer risk prediction model | Q35805572 | ||
Establishment of a mathematic model for predicting malignancy in solitary pulmonary nodules | Q36254492 | ||
Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study | Q36334146 | ||
Development and validation of clinical diagnostic models for the probability of malignancy in solitary pulmonary nodules. | Q36439356 | ||
Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment. | Q36443729 | ||
The LLP risk model: an individual risk prediction model for lung cancer | Q36614749 | ||
Role of selected genetic variants in lung cancer risk in African Americans | Q36759166 | ||
Screen-detected subsolid pulmonary nodules: long-term follow-up and application of the PanCan lung cancer risk prediction model | Q36839292 | ||
Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening | Q36984154 | ||
Incorporating epistasis interaction of genetic susceptibility single nucleotide polymorphisms in a lung cancer risk prediction model | Q36992197 | ||
Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study | Q37045787 | ||
Targeting of low-dose CT screening according to the risk of lung-cancer death | Q37198867 | ||
Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in Taiwan | Q37386375 | ||
Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next Steps | Q37513339 | ||
Selection criteria for lung-cancer screening | Q37594556 | ||
The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules | Q37615194 | ||
Application of risk prediction models to lung cancer screening: a review. | Q38360276 | ||
Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCOm2012 risk prediction tool | Q38935397 | ||
The Vancouver Lung Cancer Risk Prediction Model: Assessment by Using a Subset of the National Lung Screening Trial Cohort | Q38980508 | ||
Lung Cancer Risk Prediction Model Incorporating Lung Function: Development and Validation in the UK Biobank Prospective Cohort Study | Q39016863 | ||
A retrospective validation study of three models to estimate the probability of malignancy in patients with small pulmonary nodules from a tertiary oncology follow-up centre. | Q39138531 | ||
A Novel Pathway-Based Approach Improves Lung Cancer Risk Prediction Using Germline Genetic Variations | Q39738163 | ||
External validation is necessary in prediction research: a clinical example | Q40549827 | ||
A Modified Model for Preoperatively Predicting Malignancy of Solitary Pulmonary Nodules: An Asia Cohort Study | Q40875701 | ||
Risk of malignancy in pulmonary nodules: A validation study of four prediction models | Q41086632 | ||
Predictive Accuracy of the PanCan Lung Cancer Risk Prediction Model -External Validation based on CT from the Danish Lung Cancer Screening Trial | Q41237900 | ||
An individual risk prediction model for lung cancer based on a study in a Chinese population | Q41376066 | ||
Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelines | Q41581111 | ||
Selecting High-Risk Individuals for Lung Cancer Screening: A Prospective Evaluation of Existing Risk Models and Eligibility Criteria in the German EPIC Cohort | Q41668094 | ||
Evaluation of undiagnosed solitary lung nodules according to the probability of malignancy in the American College of Chest Physicians (ACCP) evidence-based clinical practice guidelines | Q41903827 | ||
Incorporation of a genetic factor into an epidemiologic model for prediction of individual risk of lung cancer: the Liverpool Lung Project | Q44506470 | ||
Development and validation of a clinical prediction model to estimate the probability of malignancy in solitary pulmonary nodules in Chinese people | Q45232932 | ||
Risk of development of lung cancer is increased in patients with rheumatoid arthritis: a large case control study in US veterans. | Q45331818 | ||
Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography | Q46763864 | ||
LLPi: Liverpool Lung Project Risk Prediction Model for Lung Cancer Incidence | Q47716360 | ||
The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. | Q50958688 | ||
Analysis and validation of probabilistic models for predicting malignancy in solitary pulmonary nodules in a population in Brazil. | Q51300743 | ||
Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. | Q53162511 | ||
Development and validation of diagnostic prediction model for solitary pulmonary nodules. | Q53454867 | ||
Calibration of Risk Prediction Models | Q57238751 | ||
Incremental Value of Pulmonary Function and Sputum DNA Image Cytometry in Lung Cancer Risk Prediction | Q57895945 | ||
Blood Pressure and Risk of Cancer Incidence and Mortality in the Metabolic Syndrome and Cancer Project | Q58813381 | ||
A risk model for prediction of lung cancer | Q80242314 | ||
Validation of a model of lung cancer risk prediction among smokers | Q83276607 | ||
P433 | issue | 4 | |
P304 | page(s) | 307-320 | |
P577 | publication date | 2017-10-24 | |
P1433 | published in | Current epidemiology reports | Q27725586 |
P1476 | title | Applying Risk Prediction Models to Optimize Lung Cancer Screening: Current Knowledge, Challenges, and Future Directions | |
P478 | volume | 4 |
Q64098201 | Lung cancer screening and shared decision making in cancer survivors: the long and winding road | cites work | P2860 |
Search more.